Modulation of angiogenesis
US9198981B2 · kind B2 · utility
15Cited by
3References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 17, 2006 |
| Grant date | Dec 1, 2015 |
| Priority date | — |
| Expiry date | Nov 16, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/53
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to compounds, compositions, and methods for the treatment of traits, diseases and conditions that respond to the modulation of angiogenic growth factor bioavailability or biological activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.